Analysis of outcomes in patients (pts) with relapsed/refractory acute promyelocytic leukemia (APL) treated with and without high-dose chemotherapy and hematopoietic stem cell transplantation (HCT).
N. Pemmaraju
No relevant relationships to disclose
F. Ravandi
No relevant relationships to disclose
G. Rondon
No relevant relationships to disclose
S. Giralt
No relevant relationships to disclose
J. Chen
No relevant relationships to disclose
S. Pierce
No relevant relationships to disclose
R. E. Champlin
No relevant relationships to disclose
M. De Lima
No relevant relationships to disclose
M. Qazilbash
No relevant relationships to disclose